Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institute of Cancer Research, United Kingdom
With
National Cancer Institute (NCI)
ECOG-ACRIN Cancer Research Group
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
1. Written informed consent
2. Measurable disease as determined by RECIST (version 1.1) criteria;
3. Histologically-proven squamous cell carcinoma of the penis,
4. Stage:
* any T, N1 (i.e. a palpable mobile unilateral inguinal lymph node), M0 or;
* any T, N2 (i.e. palpable mobile multiple or bilateral inguinal lymph nodes), M0 or;
* any T, N3 (i.e. fixed inguinal nodal mass or any pelvic lymphadenopathy), M0
5. Performance Status ECOG 0, 1 or 2.
You may not be if
1. Pure verrucous carcinoma of the penis,
2. Nonsquamous malignancy of the penis,
3. Squamous carcinoma of the urethra,
4. Stage M1,
5. Previous chemotherapy or chemoradiotherapy,
6. Concurrent malignancy (other than SCC or Basal Cell Carcinoma of non-penile skin) that has required surgical or non-surgical treatment in the last 3 years.
